Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 48

1.

Distinct inflammatory response patterns are evident among men and women with higher depressive symptoms.

Majd M, Graham-Engeland JE, Smyth JM, Sliwinski MJ, Lipton RB, Katz MJ, Engeland CG.

Physiol Behav. 2018 Feb 1;184:108-115. doi: 10.1016/j.physbeh.2017.11.009. Epub 2017 Nov 10.

PMID:
29133231
2.

Atypical depression: current perspectives.

Łojko D, Rybakowski JK.

Neuropsychiatr Dis Treat. 2017 Sep 20;13:2447-2456. doi: 10.2147/NDT.S147317. eCollection 2017. Review.

3.

Cytokine responses to exercise and activity in patients with chronic fatigue syndrome: case-control study.

Clark LV, Buckland M, Murphy G, Taylor N, Vleck V, Mein C, Wozniak E, Smuk M, White PD.

Clin Exp Immunol. 2017 Dec;190(3):360-371. doi: 10.1111/cei.13023. Epub 2017 Oct 11.

PMID:
28779554
4.

Immunological effects of behavioral activation with exercise in major depression: an exploratory randomized controlled trial.

Euteneuer F, Dannehl K, Del Rey A, Engler H, Schedlowski M, Rief W.

Transl Psychiatry. 2017 May 16;7(5):e1132. doi: 10.1038/tp.2017.76.

5.

Evidence for neuroplastic compensation in the cerebral cortex of persons with depressive illness.

Bansal R, Hellerstein DJ, Peterson BS.

Mol Psychiatry. 2018 Feb;23(2):375-383. doi: 10.1038/mp.2017.34. Epub 2017 Mar 7.

6.

The effects of probiotics on depressive symptoms in humans: a systematic review.

Wallace CJK, Milev R.

Ann Gen Psychiatry. 2017 Feb 20;16:14. doi: 10.1186/s12991-017-0138-2. eCollection 2017. Review. Erratum in: Ann Gen Psychiatry. 2017 Mar 7;16:18.

7.

Alteration of immune markers in a group of melancholic depressed patients and their response to electroconvulsive therapy.

Rush G, O'Donovan A, Nagle L, Conway C, McCrohan A, O'Farrelly C, Lucey JV, Malone KM.

J Affect Disord. 2016 Nov 15;205:60-68. doi: 10.1016/j.jad.2016.06.035. Epub 2016 Jun 17.

8.

Innate and adaptive immunity in the development of depression: An update on current knowledge and technological advances.

Haapakoski R, Ebmeier KP, Alenius H, Kivimäki M.

Prog Neuropsychopharmacol Biol Psychiatry. 2016 Apr 3;66:63-72. doi: 10.1016/j.pnpbp.2015.11.012. Epub 2015 Nov 26. Review.

9.

Cortisol Supplement Combined with Psychotherapy and Citalopram Improves Depression Outcomes in Patients with Hypocortisolism after Traumatic Brain Injury.

Luo L, Chai Y, Jiang R, Chen X, Yan T.

Aging Dis. 2015 Nov 17;6(6):418-25. doi: 10.14336/AD.2015.0507. eCollection 2015 Nov.

10.

IL-1β and BDNF are associated with improvement in hypersomnia but not insomnia following exercise in major depressive disorder.

Rethorst CD, Greer TL, Toups MS, Bernstein I, Carmody TJ, Trivedi MH.

Transl Psychiatry. 2015 Aug 4;5:e611. doi: 10.1038/tp.2015.104. Review.

11.

Reducing the Burden of Difficult-to-Treat Major Depressive Disorder: Revisiting Monoamine Oxidase Inhibitor Therapy.

Culpepper L.

Prim Care Companion CNS Disord. 2013;15(5). pii: PCC.13r01515. doi: 10.4088/PCC.13r01515. Epub 2013 Oct 31.

12.

From stress to inflammation and major depressive disorder: a social signal transduction theory of depression.

Slavich GM, Irwin MR.

Psychol Bull. 2014 May;140(3):774-815. doi: 10.1037/a0035302. Epub 2014 Jan 13. Review.

13.

Innovative drugs to treat depression: did animal models fail to be predictive or did clinical trials fail to detect effects?

Belzung C.

Neuropsychopharmacology. 2014 Apr;39(5):1041-51. doi: 10.1038/npp.2013.342. Epub 2013 Dec 18. Review.

14.

Symptom clusters of pain, depressed mood, and fatigue in lung cancer: assessing the role of cytokine genes.

Reyes-Gibby CC, Swartz MD, Yu X, Wu X, Yennurajalingam S, Anderson KO, Spitz MR, Shete S.

Support Care Cancer. 2013 Nov;21(11):3117-25. doi: 10.1007/s00520-013-1885-5. Epub 2013 Jul 13.

15.

Understanding the somatic consequences of depression: biological mechanisms and the role of depression symptom profile.

Penninx BW, Milaneschi Y, Lamers F, Vogelzangs N.

BMC Med. 2013 May 15;11:129. doi: 10.1186/1741-7015-11-129. Review.

16.

Treating depression and depression-like behavior with physical activity: an immune perspective.

Eyre HA, Papps E, Baune BT.

Front Psychiatry. 2013 Feb 4;4:3. doi: 10.3389/fpsyt.2013.00003. eCollection 2013.

17.

Dysregulated relationship of inflammation and oxidative stress in major depression.

Rawdin BJ, Mellon SH, Dhabhar FS, Epel ES, Puterman E, Su Y, Burke HM, Reus VI, Rosser R, Hamilton SP, Nelson JC, Wolkowitz OM.

Brain Behav Immun. 2013 Jul;31:143-52. doi: 10.1016/j.bbi.2012.11.011. Epub 2012 Nov 29.

18.

Gender differences in stress response: Role of developmental and biological determinants.

Verma R, Balhara YP, Gupta CS.

Ind Psychiatry J. 2011 Jan;20(1):4-10. doi: 10.4103/0972-6748.98407.

19.

Beta adrenergic blockade decreases the immunomodulatory effects of social disruption stress.

Hanke ML, Powell ND, Stiner LM, Bailey MT, Sheridan JF.

Brain Behav Immun. 2012 Oct;26(7):1150-9. doi: 10.1016/j.bbi.2012.07.011. Epub 2012 Jul 24.

20.

The relationship between subtypes of depression and cardiovascular disease: a systematic review of biological models.

Baune BT, Stuart M, Gilmour A, Wersching H, Heindel W, Arolt V, Berger K.

Transl Psychiatry. 2012 Mar 13;2:e92. doi: 10.1038/tp.2012.18.

Supplemental Content

Support Center